{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:33:20Z","timestamp":1787855600475,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jcmg.2016.11.015","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T20:28:34Z","timestamp":1488832114000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure"],"prefix":"10.1016","volume":"10","author":[{"given":"Hong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2016.11.015_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2016.11.015_bib2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2016.11.015_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib5","first-page":"18","article-title":"Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure","volume":"72","author":"Genovesi Ebert","year":"2009","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.jcmg.2016.11.015_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective Randomized Open Blinded End-Point (PROBE) study: a novel design for intervention trials","volume":"1","author":"Hansson","year":"1992","journal-title":"Blood Press"},{"key":"10.1016\/j.jcmg.2016.11.015_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hfc.2011.11.003","article-title":"Stage B heart failure: rationale for screening","volume":"8","author":"Atherton","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jcmg.2016.11.015_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2016.11.015_bib9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/ajrccm.167.9.950","article-title":"ATS statement on six-minute walk test","volume":"167","author":"Brooks","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2016.11.015_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2016.11.015_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/hrt.2005.080150","article-title":"Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey","volume":"92","author":"Abhayaratna","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2016.11.015_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2016.11.015_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.echo.2012.10.008","article-title":"Normal ranges of left ventricular strain: a meta-analysis","volume":"26","author":"Yingchoncharoen","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2016.11.015_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"9","author":"Schulz","year":"2011","journal-title":"Int J Surg"},{"key":"10.1016\/j.jcmg.2016.11.015_bib16","doi-asserted-by":"crossref","first-page":"e000222","DOI":"10.1136\/openhrt-2014-000222","article-title":"Clinical prediction of incident heart failure risk: a systematic review and meta-analysis","volume":"2","author":"Yang","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.jcmg.2016.11.015_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2004.07.022","article-title":"The diagnosis of heart failure in the community: Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study","volume":"44","author":"Di Bari","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2016.11.015_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jcmg.2016.11.015_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-138-11-200306030-00012","article-title":"The epidemiology of \u201casymptomatic\u201d left ventricular systolic dysfunction: implications for screening","volume":"138","author":"Wang","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib20","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2016.11.015_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","article-title":"Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure","volume":"65","author":"Kosmala","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2016.11.015_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1573403X09666131117164352","article-title":"Stage B: what is the evidence for treatment of asymptomatic left ventricular dysfunction?","volume":"11","author":"Reed","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jcmg.2016.11.015_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A\u00a0clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"Kober","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib26","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2105\/AJPH.93.8.1261","article-title":"Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition","volume":"93","author":"Glasgow","year":"2003","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jcmg.2016.11.015_bib28","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2016.11.015_bib29","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","article-title":"Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul study","volume":"167","author":"Gehi","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcmg.2016.11.015_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X16310129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X16310129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:55:36Z","timestamp":1536008136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X16310129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1936878X16310129"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.015","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}